Cidara Therapeutics, Inc. Quarterly Weighted Average Number of Shares Outstanding, Basic from Q3 2018 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Cidara Therapeutics, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q3 2018 to Q2 2024.
  • Cidara Therapeutics, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending June 30, 2024 was 4.56M shares, a 1.29% increase year-over-year.
  • Cidara Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 87.4M shares, a 25.2% increase from 2022.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 4.56M +58K +1.29% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-13
Q1 2024 4.54M +606K +15.4% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q4 2023 87.4M +17.6M +25.2% Oct 1, 2023 Dec 31, 2023 10-K 2024-04-22
Q3 2023 90.3M +20.1M +28.6% Jul 1, 2023 Sep 30, 2023 10-K 2024-04-22
Q2 2023 4.51M -64.6M -93.5% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-13
Q1 2023 3.93M -64.2M -94.2% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q4 2022 69.9M Oct 1, 2022 Dec 31, 2022 10-K 2024-04-22
Q3 2022 70.2M +20.7M +41.8% Jul 1, 2022 Sep 30, 2022 10-K 2024-04-22
Q2 2022 69.1M +20.5M +42% Apr 1, 2022 Jun 30, 2022 10-K 2024-04-22
Q1 2022 68.1M +21.2M +45.1% Jan 1, 2022 Mar 31, 2022 10-K 2024-04-22
Q3 2021 49.5M +6.33M +14.6% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 48.7M +7.71M +18.8% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 47M +9.11M +24.1% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-11
Q3 2020 43.2M +9.25M +27.2% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 41M +12.4M +43.3% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 37.9M +9.32M +32.7% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-13
Q4 2019 33.3M Oct 1, 2019 Dec 31, 2019 10-K 2020-03-04
Q3 2019 34M +6.26M +22.6% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 28.6M Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-13
Q1 2019 28.5M Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-13
Q3 2018 27.7M Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.